Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3–Mmp9 pathway
Xueyun Bi,Pengbo Lou,Yongli Song,Xiaole Sheng,Ruiqi Liu,Min Deng,Xu Yang,Guilin Li,Shukai Yuan,Honglei Zhang,Baowei Jiao,Bing Zhang,Lixiang Xue,Zhihua Liu,Maksim V. Plikus,Fazheng Ren,Shan Gao,Li Zhao,Zhengquan Yu
DOI: https://doi.org/10.1038/s41388-021-01873-8
IF: 8.756
2021-06-21
Oncogene
Abstract:Metastasis is the main cause of death in breast cancer patients. The initial step of metastasis is invadopodia-mediated extracellular matrix (ECM) degradation, which enables local breast tumor cells to invade surrounding tissues. However, the molecular mechanism underlying invadopodia-mediated metastasis remains largely unknown. Here we found that the RNA-binding protein Musashi1 (Msi1) exhibited elevated expression in invasive breast tumors and promoted lung metastasis of mammary cancer cells. Suppression of Msi1 reduced invadopodia formation in mammary cancer cells. Furthermore, Msi1 deficiency decreased the expression and activity of Mmp9, an important enzyme in ECM degradation. Mechanistically, Msi1 directly suppressed Timp3, an endogenous inhibitor of Mmp9. In clinical breast cancer specimens, TIMP3 and MSI1 levels were significantly inversely correlated both in normal breast tissue and breast cancer tissues and associated with overall survival in breast cancer patients. Taken together, our findings demonstrate that the MSI1–TIMP3–MMP9 cascade is critical for invadopodia-mediated onset of metastasis in breast cancer, providing novel insights into a promising therapeutic strategy for breast cancer metastasis.
oncology,genetics & heredity,biochemistry & molecular biology,cell biology